Emergent BioSolutions Inc.’s (EBS) Business is Vital for Homeland Security
The idea of biological warfare strikes even more fear in the human heart than a possible missile attack. Bio-terrorism assumes additional proportions of threat from the fact that it was, previously, largely untreatable. The actual experience with anthrax in the United States demonstrates the chaos which follows any report of a possible biological danger. The strategic value of Emergent BioSolutions Inc. (EBS) has roots in the Company’s effective answer regarding vaccination against anthrax. Anthrax is just one example of the kind of microbes terrorists can use. Stock investors should therefore evaluate this company in the light of its platform technology.…